The diseases we research impact people's lives
Our researchers are dedicated to improving lives through neuroscience. Thanks to the generosity of all our donors, that we can continue our legacy of ground-breaking research.
Brazil Family Foundation
Recognising stroke and motor neurone disease (MND) had only limited treatment options and no cures prompted Lyn and Bobbie Brazil to establish the Brazil Family Program for Neurology in 2017. This enabled us to recruit world-leading researchers and support four laboratories.
Dr Adam Walker’s laboratory has defined some of the early triggers of MND to enable the best targeted approaches for therapies and identified ways to prevent the abnormal accumulation or improve the removal of a protein that causes motor neurons to die.
Dr Tara Walker is examining whether the dietary supplement selenium can prevent or decrease cognitive or motor deficits following stroke.
Dr Matilde Balbi aims to understand how stimulating the cortex in different ways reduces the loss of brain cells after a stroke and whether this mitigates behavioural deficits.
Professor Gail Robinson’s stroke research aims to improve cognitive assessment tests used to evaluate stroke survivors, in the acute phase, to predict long-term outcomes and to develop more targeted, personalised therapy strategies. Professor Robinson also aims to improve our understanding of the biological basis of MND.
The Brazil Family have also donated generously to our Alzheimer’s disease research. This gift contributed to Professor Jürgen Götz and his team’s ground-breaking therapeutic ultrasound approach to target dementia. This research has identified a range of potential applications for ultrasound, including delivering drugs into the brain. The intention is to modify disease progression and ultimately cure brain diseases.
Discovery research leads to the health outcomes of the future, but it takes time and support. Researchers need preliminary data to support their applications for grants. With government grant funding becoming harder to secure , scientists with promising research potential are being lost.
Funding of researchers who narrowly miss out on government grant funding could hold the key to major breakthroughs and, with support, could continue to explore new avenues and build the data needed to be successful in subsequent grant rounds.
The Brazil Family Foundation understands the power of “near-miss” applications and are supporting our scientists with a gift which enables them to continue collecting valuable data to improve their grant success in future funding rounds.
The whole of the QBI community pays tribute to the Brazil Family Foundation whose generosity and support enables us to continue our pathway to expanding our understanding of the brain, the underlying causes of brain disease and help develop new treatments which will benefit the community at large.
Great Ocean Walk, raised over $125 000 to support
brain research.
NFIA Trekkers do the hard yards for QBI
Through the hard work of Brian Davies, a successful businessman and immediate past-president and patron of the National Fire Industry Association (NFIA), and his wife, Liz, QBI was the joint-recipient of a donation of over $250 000 in 2019.
This incredible effort was the result of the NFIA Patron’s Walk held in October, which may sound like a scenic walk in the park but Brian, Liz and seven other NFIA members spent three days enduring driving rain and winds of close to 50 knots coming straight from Antarctica.
The idea for the walk came while the couple were completing the Three Capes Walk to raise money for the Queensland Brain Institute in 2018.
On that walk, Liz suggested to Brian that as the patron of the NFIA, he could create his own walk for charity. Mr Davies believes that corporate Australia has a big responsibility to give back, which is testament to the success of the inaugural walk. The money raised was shared between the Queensland Brain Institute and the Gallipoli Medical Research Foundation (GMRF).
The NFIA walk is the first of three walks to raise money for research at QBI and GMRF, with the aim of raising $500 000 in three years. The donation from the NFIA walk will help QBI’s research into motor neurone disease, dementia, Parkinson’s disease, stroke and QBI’s Discovery Research Endowment fund, which enables fundamental research into major health issues, including depression, anxiety, PTSD and epilepsy. QBI is extremely grateful to Brian and Liz and the NFIA team for their support.
The NFIA walk is the first of three walks to raise money for research at QBI and GMRF, with the aim of raising $500 000 in three years.
The Stafford Fox Medical Research Foundation
(QBI Director) and Dr Steven Zuryn and Emeritus Professor Perry Bartlett AO (back row).
In 2019, The Stafford Fox Medical Research Foundation confirmed its continued generous support of the prestigious $2.5 million philanthropically funded international fellowship to Dr Steven Zuryn at the Queensland Brain Institute to fight stroke-induced dementia, also known as vascular dementia. The Foundation also continues to support the work of Emeritus Professor Perry Bartlett’s research into prevention of dementia in ageing by improving cognition through exercise.
The Stafford Fox Medical Research Foundation was established in 2013 following the death of Moyna Fox, and named in honour of her late husband, James Stafford Fox, a former BP Australia chief executive.
Stafford and Moyna Fox started one of Australia’s wealthiest medical research foundations after many years of careful planning, resulting in a fund worth over $100 million. It was only publicly revealed in Moyna’s will when she died in 2013, many years after her husband.
James Stafford Fox was a private person, tall, physically imposing, but without a, particularly dominant personality. He rose from a position as a junior clerk at the Port Melbourne depot of the Commonwealth Oil Refineries (COR) in 1932, to become the first Australian chief executive of BP Australia Ltd in 1971.
James Stafford Fox spent three years at the helm of BP Australia, and retired in 1974 at age 60, remaining on several boards until 1985. By 1990, he was in poor health, suffering, among other things, from dementia. He entered a nursing home and died in 1994. By that time, he had already charted the course that would lead to the establishment of the foundation. Moyna lived on for more than 18 years, knowing what would happen after her death, but never revealing it publicly. Eventually, she too succumbed to dementia and died in 2013. The couple, who were so careful with their money and who clearly had no desire for fame and prominence during their lifetime, will now forever be remembered for their generosity in setting up the Stafford Fox Medical Foundation.
The Foundation’s support of QBI is crucial in enabling Emeritus Professor Bartlett and Dr Steven Zuryn to continue their work in finding solutions for the growing challenge of dementia today. This cutting- edge research is helping put Queensland and Australia at the forefront of world medical research.
What your donations fund
Your support can help us achieve a range of achievements
World leading research
Brightest scientific minds
Solutions to global health challenges
"I think it is important for people with dementia, their families and carers, to know that they are not forgotten, and that there’s a lot of work going on behind the scenes at QBI to try to unravel the tangled web that is dementia."
– Robyn Hilton (established the Peter Hilton Senior Research Fellowship in Ageing Dementia)
Hear from one of our supporters
Jeff Maclean, Chair of QBI Advisory Board
Got a story you would like to share?
Are you a donor or supporter of QBI and would like to share your story? We would love to hear from you!
Research in action
- 5 Oct 2022Dr Lena Oestreich
Centre for Clinical Research
University of Queensland QBIC
Scientific Advisory Commitee
Associate Professor Fatima Nasrallah
Principal Research FellowQueensland Brain InstituteResearcher profile is public:1Supervisor:Researcher biography:Dr. Nasrallah is a neuroscientist with a background in magnetic resonance and interdisciplinary brain research. She graduated with a PhD in neurochemistry and NMR from the Neuroscience Research Australia Institute (NeurRA) at the University of New South Wales in 2009. In April 2009, She spent 3 years at the Singapore Bioimaging Consortium (A*STAR) where she pioneered the use of magnetic resonance imaging as a tool in cognitive brain research in the rodent. In 2013, she was appointed as senior research fellow at the Clinical Imaging Research Center where she delved into the clinical realms of human imaging. In late 2015, she returned to Australia as a Motor Accident and Injury Commission fellow at the Queensland Brain Institute (QBI) at the University of Queensland (UQ) where she independently heads her own group. Her research spans basic and clinical brain research with the the overall aim of understanding how the brain functions in health and injury, specifically, developing methods for early diagnosis of primary biomarkers following injury and translating these findings.
Body:
A/Prof Fatima Nasrallah: Functional neuroimaging and brain injuryOur laboratory aims to harness multimodality methods to identify and comprehend the fundamental mechanisms triggered following TBI. This will allow mapping of structural, functional, metabolic and molecular changes in the brain in an attempt to cross-link imaging metrics with behavioural measures and protein biomarkers, giving insight into the pathophysiology of TBI and its link to dementia.
Dr Tara Walker
Research Fellow & Group Leader, Senior Research FellowQueensland Brain InstituteResearcher profile is public:1Supervisor:Researcher biography:Dr Tara Walker is a Senior Research Associate at the Queensland Brain Institute. Dr Walker's group is investigating the mechanisms governing the lifelong production of neurons in the adult brain (adult neurogenesis). Tara studied Biotechnology as an undergraduate at the Queensland University of Technology (Brisbane, Australia), before carrying out her PhD in the field of Plant Biotechnology. In 2003 she made the transition to neuroscience, joining the Queensland Brain Institute (QBI) and the group of Professor Perry Bartlett. Here she became interested in the field of adult hippocampal neurogenesis, particularly in its activity-dependent regulation. In 2010, she joined the group of Professor Gerd Kempermann at the Center for Regenerative Therapies in Dresden, Germany, where she was awarded a Marie Curie International Incoming Fellowship in 2011. In July 2018 she returned to QBI to take up a position in the newly developed Centre for Restorative Neurosciences as a Senior Research Associate, where she will apply her knowledge of neural stem cell biology to stroke research.
Body:Research interest
We are interested in understanding the fundamental mechanisms governing the lifelong production of neurons in the adult brain. Adult neurogenesis, as this process is termed, decreases with age and this age-related decline in neurogenesis results in an associated decline in learning processes that are controlled by the hippocampus.
In previous work, together with Professor Perry Bartlett, we provided the first evidence of a true, but normally latent, hippocampal stem cell population and identified a mechanism through which the production of new neurons could be stimulated to replace or repair damaged cells in neurodegenerative diseases. More recently our focus has been on the systemic regulation of adult neurogenesis. We use the physical exercise model of increased neurogenesis to investigate cross-talk between the brain and the peripheral immune system, and in this context have investigated the interaction between T cells, mast cells and platelets and the neural stem cell niche.
The control of cell death provides a key mechanism in the regulation of adult hippocampal neurogenesis. We have demonstrated that ferroptosis, a recently identified, caspase-3-independent mode of programmed cell death, is a fundamental mechanism underlying the regulation of adult hippocampal neurogenesis. This form of cell death is mediated by the dietary trace element selenium. We have shown that selenium supplementation results in increased neural progenitor cell survival and neuronal-lineage differentiation in the hippocampus of young adult and aged mice. Ferroptotic cell death has been linked to the cell death that occurs in a number of neurodegenerative diseases and stroke. A key aspect of our future research program will be to investigate whether blocking ferroptotic cell death via dietary or environmental interventions can rescue the behavioural and cognitive decline observed in an animal model of stroke.
QBIC Management Committee
Professor Pankaj Sah
DirectorQueensland Brain InstituteResearcher profile is public:1Supervisor:Researcher biography:Professor Pankaj Sah is Director of the Queensland Brain Institute (QBI) at The University of Queensland (UQ). He is renowned for his work in understanding the neural circuitry of the amygdala, an area of the brain that plays a central role in learning and memory formation. Dysfunction of the amygdala leads to a host of anxiety-related disorders. His laboratory uses a combination of molecular tools, electrophysiology, anatomical reconstruction, calcium imaging and behavioural studies to examine the electrophysiological signatures of different brain regions and their impact on disease. Recently, his laboratory has been working with patients undergoing electrode implantation for deep brain stimulation, which is used to treat a variety of disorders such as Parkinson's disease, Tourette's syndrome and essential tremor. Professor Sah trained in medicine at The University of New South Wales and, after completing his internship, gained a PhD from the Australian National University. Following postdoctoral work at the University of California, San Francisco, and UQ, he established his own laboratory at the University of Newcastle in 1994. He then joined the John Curtin School of Medical Research at the Australian National University as a group leader in 1997. He was recruited to QBI as a founding member in 2003, and has been Director since July 2015. Professor Sah has published over 110 papers in international peer-reviewed journals. He is also the Editor-in-Chief of the Nature Partner Journal npj Science of Learning, the first journal to bring together the findings of neuroscientists, psychologists, and education researchers to understand how the brain learns.
Body:
Professor Pankaj Sah: Synaptic PlasticityThe Sah laboratory uses electrophysiology and molecular techniques, in conjunction with behavioural studies, to understand the neural circuitry that underpins learning and memory formation. Using animal models, the laboratory focusses on the part of the brain called the amygdala, and a Pavlovian learning paradigm called fear conditioning.
APCN
The Asia-Pacific Centre for Neuromodulation (APCN) is a world leader in using deep brain stimulation to revolutionise the diagnosis and treatment of neurological disease.
Co-Directors
Professor Pankaj Sah
DirectorQueensland Brain InstituteResearcher profile is public:1Supervisor:Researcher biography:Professor Pankaj Sah is Director of the Queensland Brain Institute (QBI) at The University of Queensland (UQ). He is renowned for his work in understanding the neural circuitry of the amygdala, an area of the brain that plays a central role in learning and memory formation. Dysfunction of the amygdala leads to a host of anxiety-related disorders. His laboratory uses a combination of molecular tools, electrophysiology, anatomical reconstruction, calcium imaging and behavioural studies to examine the electrophysiological signatures of different brain regions and their impact on disease. Recently, his laboratory has been working with patients undergoing electrode implantation for deep brain stimulation, which is used to treat a variety of disorders such as Parkinson's disease, Tourette's syndrome and essential tremor. Professor Sah trained in medicine at The University of New South Wales and, after completing his internship, gained a PhD from the Australian National University. Following postdoctoral work at the University of California, San Francisco, and UQ, he established his own laboratory at the University of Newcastle in 1994. He then joined the John Curtin School of Medical Research at the Australian National University as a group leader in 1997. He was recruited to QBI as a founding member in 2003, and has been Director since July 2015. Professor Sah has published over 110 papers in international peer-reviewed journals. He is also the Editor-in-Chief of the Nature Partner Journal npj Science of Learning, the first journal to bring together the findings of neuroscientists, psychologists, and education researchers to understand how the brain learns.
Body:Professor Pankaj Sah: Synaptic PlasticityThe Sah laboratory uses electrophysiology and molecular techniques, in conjunction with behavioural studies, to understand the neural circuitry that underpins learning and memory formation. Using animal models, the laboratory focusses on the part of the brain called the amygdala, and a Pavlovian learning paradigm called fear conditioning.
Honorary Professor Peter Silburn
Co-DirectorAsia-Pacific Centre for Neuromodulation, QBIHonorary ProfessorQueensland Brain InstituteResearcher profile is public:0Supervisor:Body:Professor Peter Silburn is a neurologist and world expert in the treatment and research of Parkinson’s disease. Professor Silburn was honoured for his ‘significant service to medicine as a neurologist, particularly in the treatment of neurodegenerative diseases’ with appointment as a Member of the Order of Australia (AM) in the 2013 Australia Day Honours.
Professor Silburn is a founding member and lead clinician for the Asia-Pacific Centre for Neuromodulation, a joint initiative between The University of Queensland and St Andrew’s War Memorial Hospital. Professor Silburn graduated from the University of Queensland in 1988. He commenced training in Neurology at Princess Alexandra Hospital, and completed training in Oxford at the Radcliffe Infirmary in 1995. He was subsequently the Clinical Lecturer in Neurology at the University of Oxford, United Kingdom.
From Oxford, Professor Silburn went to the Karolinska Institute, Stockholm as a Research Fellow in the Department of Molecular Medicine. Professor Silburn returned to Brisbane in July, 1996 where he commenced in private practice and began his university affiliations. He became a full Professor in Neurobiology at The University of Queensland in 2006. He maintains academic affiliations with Griffith University, Queensland University of Technology and the University of Queensland.
Research Members
Associate Professor Susannah Tye
Principal Research Fellow - GLQueensland Brain InstituteResearcher profile is public:1Supervisor:Researcher biography:Dr. Susannah Tye joined the Queensland Brain Institute in 2017 and has established a research program within the Asia Pacific Centre for Neuromodulation (QLD, Australia). Before returning to Australia, Dr. Tye directed the Translational Neuroscience Laboratory at the Mayo Clinic (2012-2017). While there she led efforts to develop brain stimulation devices (for rodents and humans) that can quantify neural activity and neurotransmitter dynamics in the living brain. This body of work now forms the basis of the neuropsychiatric arm of the Mayo Clinic's Deep Brain Stimulation Consortium. Her specific research expertise are in utilising voltammetric (electrochemical) recording techniques to monitor rapid, synaptic neurotransmission in the living brain.
Dr. Tye has over ten years of experience studying neuromodulation in preclinical rodent models and human patients. Her long-term goal is to bridge preclinical and clinical studies to maximise translational impact, specifically in terms of improving patient outcomes for those with severe refractory psychiatric illness. Towards this end, she maintains many international collaborations with both clinical and basic science researchers. Dr. Tye also has a longstanding interest in mentoring young scientists to help them expand their skills in preclinical and basic science research and achieve a successful research career.
Body:
Associate Professor Susannah Tye: Functional neuromodulation and novel therapeuticsOur research is interdisciplinary, drawing on approaches and techniques from neuroscience, molecular biology, biochemistry, and neuroengineering. We are particularly interested in the potential to use key biomarkers of refractory illness to diagnose and inform treatment decisions, and the possibility that real-time feedback may be used to customise neuromodulatory treatments. Ongoing projects in the lab address both basic and translational neuroscience questions.
Dr John Morris
Postdoctoral Research FellowQueensland Brain InstituteResearcher profile is public:1Supervisor:Mr Chiemeka Chinaka
PhD CandidateQueensland Brain InstituteResearcher profile is public:0Supervisor:
Pages
Connect with us
